94 related articles for article (PubMed ID: 15842661)
1. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.
Bödör C; Bognár A; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A
Br J Haematol; 2005 May; 129(3):373-6. PubMed ID: 15842661
[TBL] [Abstract][Full Text] [Related]
2. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
3. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
[TBL] [Abstract][Full Text] [Related]
5. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
Greeve J; Philipsen A; Krause K; Klapper W; Heidorn K; Castle BE; Janda J; Marcu KB; Parwaresch R
Blood; 2003 May; 101(9):3574-80. PubMed ID: 12511417
[TBL] [Abstract][Full Text] [Related]
6. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
7. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
Hiraga J; Katsumi A; Iwasaki T; Abe A; Kiyoi H; Matsushita T; Kinoshita T; Naoe T
Leukemia; 2007 Aug; 21(8):1846-7. PubMed ID: 17443219
[No Abstract] [Full Text] [Related]
10. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
12. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
13. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
14. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma.
Csernus B; Timár B; Fülöp Z; Bognár A; Szepesi A; László T; Jáksó P; Warnke R; Kopper L; Matolcsy A
Leuk Lymphoma; 2004 Oct; 45(10):2105-10. PubMed ID: 15370257
[TBL] [Abstract][Full Text] [Related]
16. Activation-induced cytidine deaminase expression in diffuse large B-cell lymphoma with a paracortical growth pattern: a lymphoma of possible interfollicular large B-cell origin.
Aguilera NS; Auerbach A; Barekman CL; Lichy J; Abbondanzo SL
Arch Pathol Lab Med; 2010 Mar; 134(3):449-56. PubMed ID: 20196672
[TBL] [Abstract][Full Text] [Related]
17. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
Krause K; Marcu KB; Greeve J
Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
19. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma.
Rossi D; Cerri M; Capello D; Deambrogi C; Berra E; Franceschetti S; Alabiso O; Gloghini A; Paulli M; Carbone A; Pileri SA; Pasqualucci L; Gaidano G
Leukemia; 2005 Dec; 19(12):2363-6. PubMed ID: 16208407
[No Abstract] [Full Text] [Related]
20. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
